PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 21 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

29 January 2026

  1. (diff | hist) 04:10 PolyPeptide Group (Hangzhou) 16,562 +798 ReaderRosalie (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  2. (diff | hist) 02:14 Guangzhou JEEP Biotechnology 15,452 ±0 DEXA_Dilys (talk | contribs) add the minimum order quantity for custom synthesis [rollback]

28 January 2026

  1. (diff | hist) 23:55 Lot traceability 5,317 ±0 CheckSumChase (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  2. (diff | hist) 13:20 Talk:Cold-chain freight 611 +125 FreightFenna (talk | contribs) /* A cold pack is not evidence */ reply
  3. (diff | hist) 13:20 Talk:Personal importation policy 611 +125 CustomsClarke (talk | contribs) /* Discretion versus right */ reply
  4. (diff | hist) 12:05 Talk:Glucose-dependent insulinotropic polypeptide 1,233 +195 BaselineBex (talk | contribs) /* Fasting concentration range — should this be in the infobox? */ reply
  5. (diff | hist) 10:33 Talk:Glucose-dependent insulinotropic polypeptide 1,022 +190 AnalyticalAnnie (talk | contribs) /* Fasting concentration range — should this be in the infobox? */ reply
  6. (diff | hist) 09:45 Talk:Cold-chain freight 400 +192 ColdChainCleo (talk | contribs) /* A cold pack is not evidence */ new section
  7. (diff | hist) 09:45 Talk:Personal importation policy 400 +174 ImportPolicyIggy (talk | contribs) /* Discretion versus right */ new section
  8. (diff | hist) 08:11 Talk:Glucose-dependent insulinotropic polypeptide 811 +125 BaselineBex (talk | contribs) /* Fasting concentration range — should this be in the infobox? */ new section
  9. (diff | hist) m 06:52 Cost per milligram 4,125 ±0 TesamorelinTeg (talk | contribs) serial comma per PP:MOS [rollback]
  10. (diff | hist) 06:49 Syringe dead space 19,014 +852 SigFigSindri (talk | contribs) add the note about drawing air before withdrawal [rollback]
  11. (diff | hist) m 04:45 Amylin receptor agonist 5,245 ±0 SurpassSunniva (talk | contribs) typo [rollback]
  12. (diff | hist) m 00:24 Cold chain 27,220 +70 CDMO_Caradoc (talk | contribs) convert the storage conditions to a table [rollback]
  13. (diff | hist) 00:19 AmbioPharm 13,446 +55 DPP4_Dagmar (talk | contribs) expand §Reception [rollback]

27 January 2026

  1. (diff | hist) 22:49 WuXi TIDES 16,434 ±0 AnalyticalAnnie (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  2. (diff | hist) 21:40 Methionine oxidation 5,001 ±0 TechnicianTeal (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  3. (diff | hist) 18:52 SinoPep 16,798 +1,024 MOTSc_Mira (talk | contribs) fix the anchor on an internal link [rollback]
  4. (diff | hist) 18:27 Global access disparity 4,391 ±0 ColdChainCleo (talk | contribs) correct the deductible description [rollback]
  5. (diff | hist) 14:45 Shanghai Wibson Biotechnology 15,440 ±0 CDMO_Caradoc (talk | contribs) state the city and province of the registered address [rollback]
  6. (diff | hist) 13:20 Talk:HOMA-IR 611 +89 UnitAuditUwe (talk | contribs) /* HOMA1 versus HOMA2 */ reply
  7. (diff | hist) m b 12:26 Retatrutide 7,421 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  8. (diff | hist) 12:15 Talk:Amylin 885 +194 Peptide_Pete (talk | contribs) /* Species difference in aggregation */ reply
  9. (diff | hist) 09:45 Talk:HOMA-IR 400 +146 HOMA_Hettie (talk | contribs) /* HOMA1 versus HOMA2 */ new section
  10. (diff | hist) 09:40 Talk:Amylin 674 +176 StabilityStig (talk | contribs) /* Species difference in aggregation */ new section
  11. (diff | hist) 08:50 Talk:Purity claim inflation 822 +70 NeutralNikolai (talk | contribs) /* Title implies bad faith */ reply
  12. (diff | hist) 07:52 Glucagon 7,074 ±0 ColdChainCleo (talk | contribs) add the structural figure and caption it properly [rollback]
  13. (diff | hist) 06:06 Adverse effects of GLP-1 receptor agonists 5,791 ±0 Retention_Time_Rae (talk | contribs) attribute the boxed-warning statement to the regulator that issued it [rollback]
  14. (diff | hist) 05:35 Beyond-use date 23,171 +63 StabilityStig (talk | contribs) expand §Assignment in the absence of data [rollback]
  15. (diff | hist) m 05:06 High-performance liquid chromatography 7,231 ±0 GastroparesisGwen (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]

26 January 2026

  1. (diff | hist) 20:37 Peptide harm reduction 4,800 ±0 PatientPanelPru (talk | contribs) state whether the figure is list price or net of rebate [rollback]
  2. (diff | hist) 17:34 Peptide aggregation 5,516 ±0 StateBoardStace (talk | contribs) fix indentation in the source [rollback]
  3. (diff | hist) 16:43 GLP-1 receptor 7,570 ±0 AmylinAmos (talk | contribs) British spelling per PP:MOS [rollback]
  4. (diff | hist) 13:25 Talk:SURPASS trial programme 611 +149 ForestPlotFinn (talk | contribs) /* Cross-trial comparison of SURMOUNT and STEP */ reply
  5. (diff | hist) 13:05 Talk:Purity claim inflation 611 +255 PurityClaimPia (talk | contribs) /* Title implies bad faith */ reply
  6. (diff | hist) 11:37 Talk:Glucagon-like peptide-1 1,444 +102 Ref_Desk_Ron (talk | contribs) /* Requested move: → GLP-1 */ reply
  7. (diff | hist) 09:50 Talk:SURPASS trial programme 400 +178 SurpassSunniva (talk | contribs) /* Cross-trial comparison of SURMOUNT and STEP */ new section
  8. (diff | hist) 09:30 Talk:Purity claim inflation 400 +162 NeutralNikolai (talk | contribs) /* Title implies bad faith */ new section
  9. (diff | hist) 04:14 Tirzepatide 8,037 ±0 OrforglipronOona (talk | contribs) unpipe a link that did not need piping [rollback]
  10. (diff | hist) m b 02:19 Growth hormone secretagogue 4,613 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  11. (diff | hist) m b 01:57 GLP-1 receptor agonist 11,264 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  12. (diff | hist) m 00:06 Flourishglobal Peptide Biotech 14,551 +517 BlankVialBo (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]

25 January 2026

  1. (diff | hist) 22:46 Blind sampling 8,193 ±0 Chromatokid (talk | contribs) add the turnaround time the service publishes [rollback]
  2. (diff | hist) 17:34 Reference standard 5,217 ±0 GlossaryGleb (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  3. (diff | hist) m 16:34 Lixisenatide 4,195 ±0 DulaglutideDug (talk | contribs) add category for the drug class [rollback]
  4. (diff | hist) 13:45 Talk:Dose escalation schedule 611 +121 ToleranceTove (talk | contribs) /* Selective adaptation */ reply
  5. (diff | hist) m 13:43 Prior authorisation 4,216 ±0 SemaxSevi (talk | contribs) unpipe a link that did not need piping [rollback]
  6. (diff | hist) m b 13:00 Contract development and manufacturing organisation 5,011 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) 10:10 Talk:Dose escalation schedule 400 +171 EscalationEira (talk | contribs) /* Selective adaptation */ new section
  8. (diff | hist) 09:12 Talk:Liraglutide 822 +109 DPP4_Dagmar (talk | contribs) /* DPP-4 resistance: the article contradicted itself */ reply
  9. (diff | hist) 06:44 Karl Fischer titration 9,318 ±0 TFA_Counterion (talk | contribs) add category for method validation [rollback]
  10. (diff | hist) 05:36 Sigma-Aldrich (Shanghai) Trading 18,421 ±0 FiveOhThreeA (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  11. (diff | hist) 04:46 SURPASS trial programme 5,078 ±0 AppendixAlva (talk | contribs) ce, tighten prose [rollback]
  12. (diff | hist) 04:38 Crude peptide 4,775 ±0 Ref_Desk_Ron (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  13. (diff | hist) 04:22 Timeline of incretin therapeutics 4,460 ±0 AnalyticalAnnie (talk | contribs) expand §Physiology [rollback]
  14. (diff | hist) m 01:56 Trifluoroacetate counterion 5,116 ±0 ToleranceTove (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  15. (diff | hist) 01:21 Lyophilisation 28,679 ±0 IpamorelinIsold (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]

24 January 2026

  1. (diff | hist) m b 20:13 MOTS-c 4,670 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) m b 15:49 Regulatory status by jurisdiction 4,444 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) 13:30 Talk:Liraglutide 611 +125 LiraLotte (talk | contribs) /* DPP-4 resistance: the article contradicted itself */ reply
  4. (diff | hist) 13:18 Albumin binding half-life extension 6,399 ±0 AnalyticalAnnie (talk | contribs) add a figure for the secretion time course and caption it [rollback]
  5. (diff | hist) 13:10 Talk:Intention-to-treat analysis 611 +109 ForestPlotFinn (talk | contribs) /* Adherence in the placebo arm */ reply
  6. (diff | hist) 10:05 Talk:Liraglutide 400 +210 DPP4_Dagmar (talk | contribs) /* DPP-4 resistance: the article contradicted itself */ new section
  7. (diff | hist) m b 09:59 Reverse-phase HPLC 5,499 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) 09:35 Talk:Intention-to-treat analysis 400 +172 ITT_Imelda (talk | contribs) /* Adherence in the placebo arm */ new section
  9. (diff | hist) 08:30 Talk:Multi-dose vial 1,518 +239 HarmReductionHen (talk | contribs) /* Does adding bacteriostatic water make a preparation preserved? */ reply
  10. (diff | hist) 05:54 CagriSema 5,687 ±0 INN_Ingrid (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  11. (diff | hist) 03:53 Solid-phase peptide synthesis 5,359 ±0 CustomsClarke (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]

23 January 2026

  1. (diff | hist) 23:08 Analytical method validation 5,342 ±0 CrossRefCleve (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  2. (diff | hist) m 18:12 Vial filling and stoppering 4,833 ±0 Chromatokid (talk | contribs) add the light-exposure point for photosensitive material [rollback]
  3. (diff | hist) 16:23 Temperature excursion 24,017 +1,040 Areapercent_Ayo (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  4. (diff | hist) m b 15:51 Enteroendocrine L cell 5,083 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  5. (diff | hist) 13:05 Talk:Bacterial endotoxin test 611 +60 Chromatokid (talk | contribs) /* Sterile but pyrogenic */ reply
  6. (diff | hist) 09:31 Customs seizure 4,785 ±0 StubExpanderSven (talk | contribs) close an unbalanced quotation mark [rollback]
  7. (diff | hist) 09:30 Talk:Bacterial endotoxin test 400 +169 EndotoxinEd (talk | contribs) /* Sterile but pyrogenic */ new section
  8. (diff | hist) m 09:23 Missed dose 5,277 ±0 ToleranceTove (talk | contribs) add the sharps-disposal cross-link [rollback]
  9. (diff | hist) 09:11 Talk:Glucagon-like peptide-1 1,233 +155 INN_Ingrid (talk | contribs) /* Requested move: → GLP-1 */ reply
  10. (diff | hist) 08:07 Hunan Aslsen Technology 15,492 +220 Peptide_Pete (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  11. (diff | hist) 06:11 Peptide content 8,404 ±0 INN_Ingrid (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]

22 January 2026

  1. (diff | hist) 15:30 Talk:Enteroendocrine L cell 1,022 +270 Chromatokid (talk | contribs) /* Should this article cover L-cell-derived peptides beyond GLP-1? */ reply
  2. (diff | hist) 13:48 Talk:Glucagon-like peptide-1 1,022 +346 NPOV_Nadia (talk | contribs) /* Requested move: → GLP-1 */ reply
  3. (diff | hist) 13:20 Talk:Contract development and manufacturing organisation 611 +92 GMP_Gita (talk | contribs) /* Not inherently suspicious */ reply
  4. (diff | hist) 13:05 Talk:Enteroendocrine L cell 811 +208 AnalyticalAnnie (talk | contribs) /* Should this article cover L-cell-derived peptides beyond GLP-1? */ new section
  5. (diff | hist) 12:03 Talk:Glucagon-like peptide-1 811 +192 MoveRequestMio (talk | contribs) /* Requested move: → GLP-1 */ new section
  6. (diff | hist) 11:48 Talk:Multi-dose vial 1,307 +311 Compounding_Cate (talk | contribs) /* Does adding bacteriostatic water make a preparation preserved? */ reply
  7. (diff | hist) 11:30 Counterfeit peptide 5,488 ±0 PurityClaimPia (talk | contribs) add the chain-of-custody point to §Limitations [rollback]
  8. (diff | hist) 09:45 Talk:Contract development and manufacturing organisation 400 +170 CDMO_Caradoc (talk | contribs) /* Not inherently suspicious */ new section
  9. (diff | hist) 07:57 Retention time 4,104 ±0 ResolutionRoo (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  10. (diff | hist) 07:13 Insulin syringe unit conversion 6,290 ±0 BalanceBirdie (talk | contribs) add the axis labels to the inline bar figure [rollback]

21 January 2026

  1. (diff | hist) 23:42 Electrospray ionisation 4,323 ±0 SigFigSindri (talk | contribs) add the cross-link to the compendial chapter [rollback]
  2. (diff | hist) m 21:34 Resin cleavage 4,310 ±0 SPPS_Sorrel (talk | contribs) clarify that "cold chain" without a logger is a claim, not a record [rollback]
  3. (diff | hist) 20:56 Qingdao Saber Technology Pharmaceutical 13,222 +1,024 CheckSumChase (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  4. (diff | hist) 13:45 Talk:Satiety signalling 611 +134 GlossaryGleb (talk | contribs) /* Satiation versus satiety */ reply
  5. (diff | hist) 13:10 Talk:Triple agonist 611 +114 GsCouplingGil (talk | contribs) /* Ratio comparisons across publications */ reply
  6. (diff | hist) 10:20 Talk:Satiety signalling 400 +167 SatietySunniva (talk | contribs) /* Satiation versus satiety */ new section
  7. (diff | hist) 09:35 Talk:Triple agonist 400 +136 ReceptorRhoda (talk | contribs) /* Ratio comparisons across publications */ new section
  8. (diff | hist) 09:12 Talk:Multi-dose vial 1,096 +282 BacWaterBarnaby (talk | contribs) /* Does adding bacteriostatic water make a preparation preserved? */ reply
  9. (diff | hist) m b 05:47 GL Biochem (Shanghai) 16,491 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) 05:18 GenScript Peptides 14,288 +271 PurityClaimPia (talk | contribs) state the city and province of the registered address [rollback]
  11. (diff | hist) m 01:05 Active pharmaceutical ingredient 4,569 ±0 PBM_Perrin (talk | contribs) add the note that a certificate of analysis has no regulatory standing [rollback]